Method of confirming safe delivery pathway to patient prior to energy delivery
US-12076073-B2 · Sep 3, 2024 · US
Timed energy delivery
US2016166310A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016166310-A1 |
| Application number | US-201514664269-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 20, 2015 |
| Priority date | Dec 15, 2014 |
| Publication date | Jun 16, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle determined to be optimal for reversible or irreversible effects. A method may include determining timing of the cardiac cycle and an optimal time within the cardiac cycle for energy delivery, evaluating proximity between at least one energy delivery electrode and the target tissue, and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue when, during the optimal time for energy delivery, the at least one energy delivery electrode is in close proximity with the target tissue.
First claim
Opening claim text (preview).
What is claimed is: 1 . A method of treating target tissue of a patient's heart with pulsed field energy, the heart having a cardiac cycle, the method comprising: determining timing of the cardiac cycle and an optimal time within the cardiac cycle for pulsed field energy delivery; evaluating proximity between at least one energy delivery electrode and the target tissue; and delivering pulsed field energy from the at least one energy delivery electrode to the target tissue wh…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016166310A1 cover?
- A method and system for mapping tissue and producing lesions for the treatment of cardiac arrhythmias in a non-thermal and optimal manner, minimizing the amount of energy required to selectively stun or ablate the target tissues. Energy may be delivered only at the moment(s) of best device position and proximity of an electrode to target tissue, and only during a time in the cardiac cycle deter…
- Who is the assignee on this patent?
- Medtronic Ablation Frontiers
- What technology area does this patent fall under?
- Primary CPC classification A61B18/1206. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Jun 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).